Heterocyclic compound and use thereof

TW202635653APending Publication Date: 2026-09-01FUJIAN HAIXI PHARMA CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
TW114141005
Authority / Receiving Office
TW · TW
Patent Type
Applications
Current Assignee / Owner
Priority Date
2024-10-24
Filing Date
2025-10-23
Publication Date
2026-09-01
Patent Text Reader

Abstract

The present disclosure provides tyrosine kinase inhibitors and uses thereof. Specifically, the present disclosure provides a compound of Formula (I), or a pharmaceutically acceptable salt, stereoisomer, isotopologue, solvate, or prodrug thereof, wherein each group is as defined elsewhere in the present disclosure.
Need to check novelty before this filing date? Find Prior Art